Frankfurt - Delayed Quote EUR
Fate Therapeutics, Inc. (F6T.F)
1.0760
-0.0230
(-2.09%)
As of 8:19:17 AM GMT+2. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 2.57M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| TAHL CINDY R Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 15, 2025 |
| BRESSI JEROME CHARLES Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 15, 2025 |
| TAHL CINDY R Officer | Sale at price 1.55 per share. | Direct | 8,764 | Jan 10, 2025 |
| VALAMEHR BAHRAM Chief Executive Officer | Sale at price 1.54 per share. | Direct | 13,406 | Jan 10, 2025 |
| BRESSI JEROME CHARLES Officer | Sale at price 1.55 per share. | Direct | 9,269 | Jan 10, 2025 |
| REDMILE GROUP, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.68 per share. | Indirect | 668,580 | Dec 20, 2024 |
| REDMILE GROUP, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 1.68 per share. | Indirect | 573,943 | Dec 20, 2024 |
| REDMILE GROUP, L.L.C. Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Dec 12, 2024 |
| XU YUAN Director | Sale at price 4.23 per share. | Direct | 2,678 | Aug 6, 2024 |
| TAHL CINDY R General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 29, 2024 |
| VALAMEHR BAHRAM Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 29, 2024 |
| DULAC EDWARD J III Chief Financial Officer | Sale at price 7.77 per share. | Direct | 19,013 | Mar 4, 2024 |
| DULAC EDWARD J III Chief Financial Officer | Sale at price 5.00 per share. | Direct | 9,245 | Jan 29, 2024 |
| WOLCHKO JOHN SCOTT Chief Executive Officer | Sale at price 4.37 per share. | Direct | 62,889 | Jan 9, 2024 |
| TAHL CINDY R General Counsel | Sale at price 4.37 per share. | Direct | 47,519 | Jan 9, 2024 |
| VALAMEHR BAHRAM Officer | Sale at price 4.38 per share. | Direct | 49,367 | Jan 9, 2024 |
| DULAC EDWARD J III Chief Financial Officer | Sale at price 4.37 per share. | Direct | 30,712 | Jan 9, 2024 |
| DULAC EDWARD J III Chief Financial Officer | Sale at price 3.66 per share. | Direct | 18,966 | Jan 2, 2024 |
| REDMILE GROUP, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.72 per share. | Indirect | 166,024 | Dec 26, 2023 |
| DULAC EDWARD J III Chief Financial Officer | Sale at price 3.50 per share. | Direct | 5,548 | Dec 18, 2023 |
| TAHL CINDY R General Counsel | Sale at price 2.40 per share. | Direct | 58,471 | Nov 9, 2023 |
| DULAC EDWARD J III Chief Financial Officer | Sale at price 2.80 per share. | Direct | 13,210 | Aug 18, 2023 |
| XU YUAN Director | Sale at price 3.71 per share. | Direct | 2,345 | Aug 4, 2023 |
| DULAC EDWARD J III Chief Financial Officer | Sale at price 4.83 per share. | Direct | 25,029 | Jul 5, 2023 |
| POWL BRIAN T Officer | Sale at price 4.87 per share. | Direct | 18,769 | Jul 5, 2023 |
| XU YUAN Director | Sale at price 5.58 per share. | Direct | 19,307 | Jun 14, 2023 |
Related Tickers
AVU0.F Adverum Biotechnologies, Inc.
2.5000
-0.79%
HXBM Helix BioMedix, Inc.
7.18
0.00%
1JK.F Apellis Pharmaceuticals, Inc.
15.14
+3.73%
38I.F Intellia Therapeutics, Inc.
7.18
+4.09%
1T3.F Syndax Pharmaceuticals, Inc.
11.50
+0.88%
CDTTW Conduit Pharmaceuticals Inc.
0.0073
-36.52%
ANTX AN2 Therapeutics, Inc.
1.2550
+1.21%
THRD Third Harmonic Bio, Inc.
5.14
-0.19%
SION Sionna Therapeutics, Inc.
12.04
0.00%
TYRA Tyra Biosciences, Inc.
10.15
-1.89%